The global market for Brain Tumor Therapeutics was valued at US$ 1388 million in the year 2024 and is projected to reach a revised size of US$ 2749 million by 2031, growing at a CAGR of 10.4% during the forecast period.

Brain Tumor Therapeutics Market

A brain tumor occurs when abnormal cells form within the brain.

North America dominates the brain tumor therapeutics market due to increasing technological advancements and the rising incidences of brain cancer in the country. Asia-Pacific is also expected to propel the brain tumor therapeutics market owing to factors, such as increasing accessibility to healthcare facilities in the region, and increasing geriatric population.

This report aims to provide a comprehensive presentation of the global market for Brain Tumor Therapeutics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Brain Tumor Therapeutics.

The Brain Tumor Therapeutics market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Brain Tumor Therapeutics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Brain Tumor Therapeutics companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Brain Tumor Therapeutics Market Report

Report Metric	Details
Report Name	Brain Tumor Therapeutics Market
Accounted market size in year	US$ 1388 million
Forecasted market size in 2031	US$ 2749 million
CAGR	10.4%
Base Year	year
Forecasted years	2025 - 2031
Segment by Type	Surgery Radiation Therapy Targeted Therapy Chemotherapy Immunotherapy
Segment by Application	Hospitals Oncology Treatment Centers Others
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Pfizer, Novartis, Roche, Merck, AstraZeneca, GE Healthcare, Hitachi Medical, Philips Healthcare, Novocure, DelMar Pharmaceuticals
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Brain Tumor Therapeutics company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Brain Tumor Therapeutics Market growing?

Ans: The Brain Tumor Therapeutics Market witnessing a CAGR of 10.4% during the forecast period 2025-2031.

What is the Brain Tumor Therapeutics Market size in 2031?

Ans: The Brain Tumor Therapeutics Market size in 2031 will be US$ 2749 million.

Who are the main players in the Brain Tumor Therapeutics Market report?

Ans: The main players in the Brain Tumor Therapeutics Market are Pfizer, Novartis, Roche, Merck, AstraZeneca, GE Healthcare, Hitachi Medical, Philips Healthcare, Novocure, DelMar Pharmaceuticals

What are the Application segmentation covered in the Brain Tumor Therapeutics Market report?

Ans: The Applications covered in the Brain Tumor Therapeutics Market report are Hospitals, Oncology Treatment Centers, Others

What are the Type segmentation covered in the Brain Tumor Therapeutics Market report?

Ans: The Types covered in the Brain Tumor Therapeutics Market report are Surgery, Radiation Therapy, Targeted Therapy, Chemotherapy, Immunotherapy

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Brain Tumor Therapeutics Market Size Growth Rate by Type: 2020 VS 2024 VS 2031

1.2.2 Surgery

1.2.3 Radiation Therapy

1.2.4 Targeted Therapy

1.2.5 Chemotherapy

1.2.6 Immunotherapy

1.3 Market by Application

1.3.1 Global Brain Tumor Therapeutics Market Growth by Application: 2020 VS 2024 VS 2031

1.3.2 Hospitals

1.3.3 Oncology Treatment Centers

1.3.4 Others

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Brain Tumor Therapeutics Market Perspective (2020-2031)

2.2 Global Brain Tumor Therapeutics Growth Trends by Region

2.2.1 Global Brain Tumor Therapeutics Market Size by Region: 2020 VS 2024 VS 2031

2.2.2 Brain Tumor Therapeutics Historic Market Size by Region (2020-2025)

2.2.3 Brain Tumor Therapeutics Forecasted Market Size by Region (2026-2031)

2.3 Brain Tumor Therapeutics Market Dynamics

2.3.1 Brain Tumor Therapeutics Industry Trends

2.3.2 Brain Tumor Therapeutics Market Drivers

2.3.3 Brain Tumor Therapeutics Market Challenges

2.3.4 Brain Tumor Therapeutics Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Brain Tumor Therapeutics Players by Revenue

3.1.1 Global Top Brain Tumor Therapeutics Players by Revenue (2020-2025)

3.1.2 Global Brain Tumor Therapeutics Revenue Market Share by Players (2020-2025)

3.2 Global Brain Tumor Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by Brain Tumor Therapeutics Revenue

3.4 Global Brain Tumor Therapeutics Market Concentration Ratio

3.4.1 Global Brain Tumor Therapeutics Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Brain Tumor Therapeutics Revenue in 2024

3.5 Global Key Players of Brain Tumor Therapeutics Head office and Area Served

3.6 Global Key Players of Brain Tumor Therapeutics, Product and Application

3.7 Global Key Players of Brain Tumor Therapeutics, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Brain Tumor Therapeutics Breakdown Data by Type

4.1 Global Brain Tumor Therapeutics Historic Market Size by Type (2020-2025)

4.2 Global Brain Tumor Therapeutics Forecasted Market Size by Type (2026-2031)

5 Brain Tumor Therapeutics Breakdown Data by Application

5.1 Global Brain Tumor Therapeutics Historic Market Size by Application (2020-2025)

5.2 Global Brain Tumor Therapeutics Forecasted Market Size by Application (2026-2031)

6 North America

6.1 North America Brain Tumor Therapeutics Market Size (2020-2031)

6.2 North America Brain Tumor Therapeutics Market Growth Rate by Country: 2020 VS 2024 VS 2031

6.3 North America Brain Tumor Therapeutics Market Size by Country (2020-2025)

6.4 North America Brain Tumor Therapeutics Market Size by Country (2026-2031)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Brain Tumor Therapeutics Market Size (2020-2031)

7.2 Europe Brain Tumor Therapeutics Market Growth Rate by Country: 2020 VS 2024 VS 2031

7.3 Europe Brain Tumor Therapeutics Market Size by Country (2020-2025)

7.4 Europe Brain Tumor Therapeutics Market Size by Country (2026-2031)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Brain Tumor Therapeutics Market Size (2020-2031)

8.2 Asia-Pacific Brain Tumor Therapeutics Market Growth Rate by Region: 2020 VS 2024 VS 2031

8.3 Asia-Pacific Brain Tumor Therapeutics Market Size by Region (2020-2025)

8.4 Asia-Pacific Brain Tumor Therapeutics Market Size by Region (2026-2031)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Brain Tumor Therapeutics Market Size (2020-2031)

9.2 Latin America Brain Tumor Therapeutics Market Growth Rate by Country: 2020 VS 2024 VS 2031

9.3 Latin America Brain Tumor Therapeutics Market Size by Country (2020-2025)

9.4 Latin America Brain Tumor Therapeutics Market Size by Country (2026-2031)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Brain Tumor Therapeutics Market Size (2020-2031)

10.2 Middle East & Africa Brain Tumor Therapeutics Market Growth Rate by Country: 2020 VS 2024 VS 2031

10.3 Middle East & Africa Brain Tumor Therapeutics Market Size by Country (2020-2025)

10.4 Middle East & Africa Brain Tumor Therapeutics Market Size by Country (2026-2031)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Pfizer

11.1.1 Pfizer Company Details

11.1.2 Pfizer Business Overview

11.1.3 Pfizer Brain Tumor Therapeutics Introduction

11.1.4 Pfizer Revenue in Brain Tumor Therapeutics Business (2020-2025)

11.1.5 Pfizer Recent Development

11.2 Novartis

11.2.1 Novartis Company Details

11.2.2 Novartis Business Overview

11.2.3 Novartis Brain Tumor Therapeutics Introduction

11.2.4 Novartis Revenue in Brain Tumor Therapeutics Business (2020-2025)

11.2.5 Novartis Recent Development

11.3 Roche

11.3.1 Roche Company Details

11.3.2 Roche Business Overview

11.3.3 Roche Brain Tumor Therapeutics Introduction

11.3.4 Roche Revenue in Brain Tumor Therapeutics Business (2020-2025)

11.3.5 Roche Recent Development

11.4 Merck

11.4.1 Merck Company Details

11.4.2 Merck Business Overview

11.4.3 Merck Brain Tumor Therapeutics Introduction

11.4.4 Merck Revenue in Brain Tumor Therapeutics Business (2020-2025)

11.4.5 Merck Recent Development

11.5 AstraZeneca

11.5.1 AstraZeneca Company Details

11.5.2 AstraZeneca Business Overview

11.5.3 AstraZeneca Brain Tumor Therapeutics Introduction

11.5.4 AstraZeneca Revenue in Brain Tumor Therapeutics Business (2020-2025)

11.5.5 AstraZeneca Recent Development

11.6 GE Healthcare

11.6.1 GE Healthcare Company Details

11.6.2 GE Healthcare Business Overview

11.6.3 GE Healthcare Brain Tumor Therapeutics Introduction

11.6.4 GE Healthcare Revenue in Brain Tumor Therapeutics Business (2020-2025)

11.6.5 GE Healthcare Recent Development

11.7 Hitachi Medical

11.7.1 Hitachi Medical Company Details

11.7.2 Hitachi Medical Business Overview

11.7.3 Hitachi Medical Brain Tumor Therapeutics Introduction

11.7.4 Hitachi Medical Revenue in Brain Tumor Therapeutics Business (2020-2025)

11.7.5 Hitachi Medical Recent Development

11.8 Philips Healthcare

11.8.1 Philips Healthcare Company Details

11.8.2 Philips Healthcare Business Overview

11.8.3 Philips Healthcare Brain Tumor Therapeutics Introduction

11.8.4 Philips Healthcare Revenue in Brain Tumor Therapeutics Business (2020-2025)

11.8.5 Philips Healthcare Recent Development

11.9 Novocure

11.9.1 Novocure Company Details

11.9.2 Novocure Business Overview

11.9.3 Novocure Brain Tumor Therapeutics Introduction

11.9.4 Novocure Revenue in Brain Tumor Therapeutics Business (2020-2025)

11.9.5 Novocure Recent Development

11.10 DelMar Pharmaceuticals

11.10.1 DelMar Pharmaceuticals Company Details

11.10.2 DelMar Pharmaceuticals Business Overview

11.10.3 DelMar Pharmaceuticals Brain Tumor Therapeutics Introduction

11.10.4 DelMar Pharmaceuticals Revenue in Brain Tumor Therapeutics Business (2020-2025)

11.10.5 DelMar Pharmaceuticals Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

DelMar Pharmaceuticals

List of Tables

Table 1. Global Brain Tumor Therapeutics Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Key Players of Surgery

Table 3. Key Players of Radiation Therapy

Table 4. Key Players of Targeted Therapy

Table 5. Key Players of Chemotherapy

Table 6. Key Players of Immunotherapy

Table 7. Global Brain Tumor Therapeutics Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 8. Global Brain Tumor Therapeutics Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 9. Global Brain Tumor Therapeutics Market Size by Region (2020-2025) & (US$ Million)

Table 10. Global Brain Tumor Therapeutics Market Share by Region (2020-2025)

Table 11. Global Brain Tumor Therapeutics Forecasted Market Size by Region (2026-2031) & (US$ Million)

Table 12. Global Brain Tumor Therapeutics Market Share by Region (2026-2031)

Table 13. Brain Tumor Therapeutics Market Trends

Table 14. Brain Tumor Therapeutics Market Drivers

Table 15. Brain Tumor Therapeutics Market Challenges

Table 16. Brain Tumor Therapeutics Market Restraints

Table 17. Global Brain Tumor Therapeutics Revenue by Players (2020-2025) & (US$ Million)

Table 18. Global Brain Tumor Therapeutics Market Share by Players (2020-2025)

Table 19. Global Top Brain Tumor Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Brain Tumor Therapeutics as of 2024)

Table 20. Ranking of Global Top Brain Tumor Therapeutics Companies by Revenue (US$ Million) in 2024

Table 21. Global 5 Largest Players Market Share by Brain Tumor Therapeutics Revenue (CR5 and HHI) & (2020-2025)

Table 22. Global Key Players of Brain Tumor Therapeutics, Headquarters and Area Served

Table 23. Global Key Players of Brain Tumor Therapeutics, Product and Application

Table 24. Global Key Players of Brain Tumor Therapeutics, Date of Enter into This Industry

Table 25. Mergers & Acquisitions, Expansion Plans

Table 26. Global Brain Tumor Therapeutics Market Size by Type (2020-2025) & (US$ Million)

Table 27. Global Brain Tumor Therapeutics Revenue Market Share by Type (2020-2025)

Table 28. Global Brain Tumor Therapeutics Forecasted Market Size by Type (2026-2031) & (US$ Million)

Table 29. Global Brain Tumor Therapeutics Revenue Market Share by Type (2026-2031)

Table 30. Global Brain Tumor Therapeutics Market Size by Application (2020-2025) & (US$ Million)

Table 31. Global Brain Tumor Therapeutics Revenue Market Share by Application (2020-2025)

Table 32. Global Brain Tumor Therapeutics Forecasted Market Size by Application (2026-2031) & (US$ Million)

Table 33. Global Brain Tumor Therapeutics Revenue Market Share by Application (2026-2031)

Table 34. North America Brain Tumor Therapeutics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 35. North America Brain Tumor Therapeutics Market Size by Country (2020-2025) & (US$ Million)

Table 36. North America Brain Tumor Therapeutics Market Size by Country (2026-2031) & (US$ Million)

Table 37. Europe Brain Tumor Therapeutics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 38. Europe Brain Tumor Therapeutics Market Size by Country (2020-2025) & (US$ Million)

Table 39. Europe Brain Tumor Therapeutics Market Size by Country (2026-2031) & (US$ Million)

Table 40. Asia-Pacific Brain Tumor Therapeutics Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031

Table 41. Asia-Pacific Brain Tumor Therapeutics Market Size by Region (2020-2025) & (US$ Million)

Table 42. Asia-Pacific Brain Tumor Therapeutics Market Size by Region (2026-2031) & (US$ Million)

Table 43. Latin America Brain Tumor Therapeutics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 44. Latin America Brain Tumor Therapeutics Market Size by Country (2020-2025) & (US$ Million)

Table 45. Latin America Brain Tumor Therapeutics Market Size by Country (2026-2031) & (US$ Million)

Table 46. Middle East & Africa Brain Tumor Therapeutics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 47. Middle East & Africa Brain Tumor Therapeutics Market Size by Country (2020-2025) & (US$ Million)

Table 48. Middle East & Africa Brain Tumor Therapeutics Market Size by Country (2026-2031) & (US$ Million)

Table 49. Pfizer Company Details

Table 50. Pfizer Business Overview

Table 51. Pfizer Brain Tumor Therapeutics Product

Table 52. Pfizer Revenue in Brain Tumor Therapeutics Business (2020-2025) & (US$ Million)

Table 53. Pfizer Recent Development

Table 54. Novartis Company Details

Table 55. Novartis Business Overview

Table 56. Novartis Brain Tumor Therapeutics Product

Table 57. Novartis Revenue in Brain Tumor Therapeutics Business (2020-2025) & (US$ Million)

Table 58. Novartis Recent Development

Table 59. Roche Company Details

Table 60. Roche Business Overview

Table 61. Roche Brain Tumor Therapeutics Product

Table 62. Roche Revenue in Brain Tumor Therapeutics Business (2020-2025) & (US$ Million)

Table 63. Roche Recent Development

Table 64. Merck Company Details

Table 65. Merck Business Overview

Table 66. Merck Brain Tumor Therapeutics Product

Table 67. Merck Revenue in Brain Tumor Therapeutics Business (2020-2025) & (US$ Million)

Table 68. Merck Recent Development

Table 69. AstraZeneca Company Details

Table 70. AstraZeneca Business Overview

Table 71. AstraZeneca Brain Tumor Therapeutics Product

Table 72. AstraZeneca Revenue in Brain Tumor Therapeutics Business (2020-2025) & (US$ Million)

Table 73. AstraZeneca Recent Development

Table 74. GE Healthcare Company Details

Table 75. GE Healthcare Business Overview

Table 76. GE Healthcare Brain Tumor Therapeutics Product

Table 77. GE Healthcare Revenue in Brain Tumor Therapeutics Business (2020-2025) & (US$ Million)

Table 78. GE Healthcare Recent Development

Table 79. Hitachi Medical Company Details

Table 80. Hitachi Medical Business Overview

Table 81. Hitachi Medical Brain Tumor Therapeutics Product

Table 82. Hitachi Medical Revenue in Brain Tumor Therapeutics Business (2020-2025) & (US$ Million)

Table 83. Hitachi Medical Recent Development

Table 84. Philips Healthcare Company Details

Table 85. Philips Healthcare Business Overview

Table 86. Philips Healthcare Brain Tumor Therapeutics Product

Table 87. Philips Healthcare Revenue in Brain Tumor Therapeutics Business (2020-2025) & (US$ Million)

Table 88. Philips Healthcare Recent Development

Table 89. Novocure Company Details

Table 90. Novocure Business Overview

Table 91. Novocure Brain Tumor Therapeutics Product

Table 92. Novocure Revenue in Brain Tumor Therapeutics Business (2020-2025) & (US$ Million)

Table 93. Novocure Recent Development

Table 94. DelMar Pharmaceuticals Company Details

Table 95. DelMar Pharmaceuticals Business Overview

Table 96. DelMar Pharmaceuticals Brain Tumor Therapeutics Product

Table 97. DelMar Pharmaceuticals Revenue in Brain Tumor Therapeutics Business (2020-2025) & (US$ Million)

Table 98. DelMar Pharmaceuticals Recent Development

Table 99. Research Programs/Design for This Report

Table 100. Key Data Information from Secondary Sources

Table 101. Key Data Information from Primary Sources

Table 102. Authors List of This Report

List of Figures

Figure 1. Brain Tumor Therapeutics Picture

Figure 2. Global Brain Tumor Therapeutics Market Size Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Brain Tumor Therapeutics Market Share by Type: 2024 VS 2031

Figure 4. Surgery Features

Figure 5. Radiation Therapy Features

Figure 6. Targeted Therapy Features

Figure 7. Chemotherapy Features

Figure 8. Immunotherapy Features

Figure 9. Global Brain Tumor Therapeutics Market Size by Application (2020-2031) & (US$ Million)

Figure 10. Global Brain Tumor Therapeutics Market Share by Application: 2024 VS 2031

Figure 11. Hospitals Case Studies

Figure 12. Oncology Treatment Centers Case Studies

Figure 13. Others Case Studies

Figure 14. Brain Tumor Therapeutics Report Years Considered

Figure 15. Global Brain Tumor Therapeutics Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 16. Global Brain Tumor Therapeutics Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 17. Global Brain Tumor Therapeutics Market Share by Region: 2024 VS 2031

Figure 18. Global Brain Tumor Therapeutics Market Share by Players in 2024

Figure 19. Global Top Brain Tumor Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Brain Tumor Therapeutics as of 2024)

Figure 20. The Top 10 and 5 Players Market Share by Brain Tumor Therapeutics Revenue in 2024

Figure 21. North America Brain Tumor Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 22. North America Brain Tumor Therapeutics Market Share by Country (2020-2031)

Figure 23. United States Brain Tumor Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 24. Canada Brain Tumor Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 25. Europe Brain Tumor Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 26. Europe Brain Tumor Therapeutics Market Share by Country (2020-2031)

Figure 27. Germany Brain Tumor Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 28. France Brain Tumor Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 29. U.K. Brain Tumor Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 30. Italy Brain Tumor Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 31. Russia Brain Tumor Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 32. Nordic Countries Brain Tumor Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 33. Asia-Pacific Brain Tumor Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 34. Asia-Pacific Brain Tumor Therapeutics Market Share by Region (2020-2031)

Figure 35. China Brain Tumor Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 36. Japan Brain Tumor Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 37. South Korea Brain Tumor Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 38. Southeast Asia Brain Tumor Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 39. India Brain Tumor Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 40. Australia Brain Tumor Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 41. Latin America Brain Tumor Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 42. Latin America Brain Tumor Therapeutics Market Share by Country (2020-2031)

Figure 43. Mexico Brain Tumor Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 44. Brazil Brain Tumor Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 45. Middle East & Africa Brain Tumor Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 46. Middle East & Africa Brain Tumor Therapeutics Market Share by Country (2020-2031)

Figure 47. Turkey Brain Tumor Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 48. Saudi Arabia Brain Tumor Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 49. UAE Brain Tumor Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 50. Pfizer Revenue Growth Rate in Brain Tumor Therapeutics Business (2020-2025)

Figure 51. Novartis Revenue Growth Rate in Brain Tumor Therapeutics Business (2020-2025)

Figure 52. Roche Revenue Growth Rate in Brain Tumor Therapeutics Business (2020-2025)

Figure 53. Merck Revenue Growth Rate in Brain Tumor Therapeutics Business (2020-2025)

Figure 54. AstraZeneca Revenue Growth Rate in Brain Tumor Therapeutics Business (2020-2025)

Figure 55. GE Healthcare Revenue Growth Rate in Brain Tumor Therapeutics Business (2020-2025)

Figure 56. Hitachi Medical Revenue Growth Rate in Brain Tumor Therapeutics Business (2020-2025)

Figure 57. Philips Healthcare Revenue Growth Rate in Brain Tumor Therapeutics Business (2020-2025)

Figure 58. Novocure Revenue Growth Rate in Brain Tumor Therapeutics Business (2020-2025)

Figure 59. DelMar Pharmaceuticals Revenue Growth Rate in Brain Tumor Therapeutics Business (2020-2025)

Figure 60. Bottom-up and Top-down Approaches for This Report

Figure 61. Data Triangulation

Figure 62. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global Brain Cancer Targeted Drug Market Research Report 2025

Global Solid Tumor Therapeutics Market Research Report 2024

Global Brain Tumor Diagnosis and Therapeutics Market Insights Forecast to 2030

Global Brain and Central Nervous System Cancer Treatments Market Research Report 2024

Global Adult Malignant Glioma Therapeutics Market Insights Forecast to 2030

Global Oncology Therapeutic Drug Market Research Report 2024

Tumor Treatment Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Cell Separation and Characterization in Solid Tumors Market Insights Forecast to 2030

Global Drugs for Oncology Market Insights Forecast to 2030

Brain Tumor Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Oncology Drugs Market Insights Forecast to 2030

Global Solid Tumor Cancer Treatment Market Insights Forecast to 2030

Global Brain Tumor Diagnostics and Therapeutics Market Research Report 2024

Oncology Treatment Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Malignant Glioma Therapeutics Market Research Report 2024

Global Targeted Therapy for Breast Cancer Market Research Report 2025

Oncology Medication Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Rectal Cancer Therapeutics Market Insights Forecast to 2030

Global Brain Cancer Molecular Diagnostics Market Research Report 2024

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions